Focus

Signal Peak invests in information technology companies that can capture significant market share in large, high growth markets as a result of a proprietary technology, product, or service.  Signal Peak partners with companies developing credible business models likely to lead to profitable operations.

Exit

At Signal Peak, we are proud of our portfolio companies and the entrepreneurs who founded them. Our portfolio companies have experienced teams, sound value propositions, and unfair advantages that will allow them to win.

Rocky Mountain Region

Signal Peak focuses its investments in the Rocky Mountain Region. The region offers a technology rich base of entrepreneurs and our team has decades of successful experience assisting companies in the Intermountain States.

Experience

So what makes Signal Peak qualified to help? Experience. Collectively, the Signal Peak team has founded, served as senior officers or board members of over 75 companies. Combined, the team has a history of successful company leadership and private equity investments that span over 60 years. As a result, our team has the resources, decision-making experience, and relationships to meet the demands of today's entrepreneurs.

Growth

Signal Peak invests in early and mid-stage high technology ventures. Our firm strives to have meaningful ownership positions with our investments and actively contribute as advisors and directors to our companies.

view all

PRESS RELEASES

Jul 23, 2014

Leading Consumer & Small Business Technology Support Provider iTOK, Inc. Secures $18 Million Investment

iTOK, Inc., a provider of IT-managed services and cloud-based software solutions for individuals and small businesses, today announced a Series B $18 million round of equity financing.
Jul 16, 2014

Will It Fit? This Algorithm Takes The Guesswork Out Of Online Shopping

True Fit, a retail software startup that just raised $10.6 million in equity funding, uses data analytics to take the guesswork out of online shopping.
Jul 7, 2014

Q Therapeutics Announces First U.S. Patent Relating to Fifth Patent Family on Neural Cells

Q Therapeutics, Inc. ("Q"), an emerging biotechnology company developing innovative cell therapy products for the treatment of debilitating diseases of the central nervous system, announced today that the United States Patent and Trademark Office has issued the Company the first U.S. patent from its fifth patent family on neural cells.
Jun 26, 2014

Graduation Alliance acquires ConnectEDU assets

Graduation Alliance, which partners with school districts across the United States to serve at-risk students, announced on Thursday it has acquired key assets from college and career planning company ConnectEDU.